Efficacy and immunogenicity of rKVAC85B in a BCG prime-boost regimen against H37Rv and HN878 Mycobacterium tuberculosis strains. Shin E, Yun JS, Lee YR, Cha HR, et al. PLoS One 2025;20:e0322147.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shin E, Yun JS, Lee YR, Cha HR, et al. Efficacy and immunogenicity of rKVAC85B in a BCG prime-boost regimen against H37Rv and HN878 Mycobacterium tuberculosis strains. PLoS One 2025;20:e0322147.
PMID: 40367100